abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Shares, $0.01 par value
Shares outstanding: 28,862,386
Number of holders: 56
Total 13F shares, excl. options: 4,667,693
Shares change: +157,625
Total reported value, excl. options: $82,119,114
Value change: +$2,719,515
Number of buys: 34
Number of sells: -22
Price: $17.58

Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2020

67 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q3 2020.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,667,693 shares of 28,862,386 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (485,000 shares), MORGAN STANLEY (445,101 shares), 1832 Asset Management L.P. (434,400 shares), Advisors Asset Management, Inc. (331,034 shares), Matisse Capital (319,311 shares), FLAGSHIP HARBOR ADVISORS, LLC (293,395 shares), WELLS FARGO & COMPANY/MN (285,826 shares), COHEN & STEERS, INC. (259,966 shares), LAZARD ASSET MANAGEMENT LLC (204,462 shares), and 1607 Capital Partners, LLC (202,988 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.